Anthropic Overtakes OpenAI with $1 Trillion Valuation Amid Investor Frenzy
Updated
Updated · Business Insider · Apr 23
Anthropic Overtakes OpenAI with $1 Trillion Valuation Amid Investor Frenzy
53 articles · Updated · Business Insider · Apr 23
Anthropic has reached a $1 trillion valuation on secondary markets, overtaking OpenAI as the world’s most valuable private AI company.
Demand for Anthropic shares has surged, with investors offering unprecedented prices and existing shareholders receiving multiple daily offers to sell.
Anthropic’s rapid ascent reflects investor confidence in its enterprise growth and AI safety approach, reshaping the power dynamics of the AI industry.
Why is Anthropic's enterprise-first strategy suddenly winning against OpenAI's consumer approach?
Is Anthropic's $1 trillion valuation a sign of market dominance or a massive speculative bubble?
After defying the government on AI safety, what is the ultimate price Anthropic will pay?
Can Anthropic truly contain its powerful hacking AI from being catastrophically misused?
Could Anthropic's IPO trigger the largest single philanthropic donation in history?
Is 'Constitutional AI' a genuine safety breakthrough or just a brilliant marketing strategy?
Inside Anthropic’s Meteoric Rise: $30 Billion Revenue Run-Rate, Claude Mythos, and Pentagon Fallout
Overview
In early 2026, Anthropic's annual revenue soared from $9 billion to $30 billion, driven by strong enterprise demand for its coding-focused AI tools. The April launch of Claude Mythos further accelerated growth and sparked investor excitement, leading to $800 billion valuation offers and belief in a $1 trillion valuation. Anthropic's enterprise-first strategy, featuring deep integration through tools like Claude Code and partnerships with firms like Microsoft and Intuit, set it apart from competitors. However, its ethical stance against military contracts led to a Pentagon supply-chain risk designation, causing revenue loss but boosting its reputation. Meanwhile, Mythos's cybersecurity breakthroughs raised global regulatory concerns, prompting cautious, controlled deployment.